A Waukesha County deputy is battling a "rare, aggressive cancer." Steve Lyles has been with the department for nearly 20 ...

Metastatic papillary renal cancer has poor outcomes, and new treatments are needed. There is a strong rationale for investigating the combination of mesenchymal epithelial transition receptor (MET) ...

The combination of savolitinib and durvalumab demonstrated durable activity in a phase 2 trial of patients with papillary RCC.

Due to the ongoing shortage of BCG, gemcitabine has been increasingly used for first-line NMIBC therapy. N-803’s ability to activate natural killer and CD8+ T cells, thus the innate immune system, to ...

ImmunityBio (IBRX) announced the Medicines and Healthcare products Regulatory Agency has validated and accepted the marketing authorization ...

Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...

Objective: To characterize and further compare the immune cell populations of the tumor microenvironment (TME) in both clear cell and papillary renal cell carcinoma (RCC) using heavy metal-labeled ...

There is a description of a horseshoe vascular pattern, which was not observed in the present case. 3, 5 SCAP can infect, bleed, ulcerate, and, in rare cases, it can progress to basal cell carcinoma ...

Treatment patterns in patients with advanced gastrointestinal stromal tumor in Japan: An administrative claims database study.

Department of Laboratory Medicine, Peking University Third Hospital, Beijing 100191, China Core Unit of National Clinical Research Center for Laboratory Medicine, Peking University Third Hospital, ...